MDS
MDS specializes in the fields of joining/feeding technology, special machine construction, as well as punching, and forming technology.
MDS
Industry:
Industrial Automation Machine Learning
Founded:
2003-01-01
Address:
Regensburg, Bayern, Germany
Country:
Germany
Website Url:
http://www.mds-r.de
Total Employee:
51+
Status:
Active
Contact:
49 (941) 60 42-210
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Official Site Inspections
http://www.mds-r.de
- Host name: deb-isp-srv6.conceptnet.de
- IP address: 212.77.185.89
- Location: Regensburg Germany
- Latitude: 48.9913
- Longitude: 12.1106
- Timezone: Europe/Berlin
- Postal: 93053
More informations about "MDS"
MDS Foundation | MDS is a bone marrow failure disorder
We are a global non-profit advocacy organization building critical awareness of Myelodysplastic Syndromes (MDS) - a rare, often undetected blood cancer. The MDS Foundation has …See details»
Myelodysplastic syndromes | Canadian Cancer Society
Myelodysplastic syndromes (MDSs) are a group of diseases where the bone marrow does not make enough healthy blood cells. Instead the bone marrow makes immature blood cells, …See details»
Diagnosis and classification of myelodysplastic …
Dec 28, 2023 · Myelodysplastic syndromes (MDSs) are neoplastic myeloid proliferations characterized by ineffective hematopoiesis resulting in peripheral blood cytopenias. MDS is distinguished from nonneoplastic clonal myeloid …See details»
Myelodysplastic Syndromes - Symptoms, Causes, Treatment | NORD
Jan 18, 2024 · Learn about Myelodysplastic Syndromes, including symptoms, causes, and treatments. If you or a loved one is affected by this condition, visit NORD to find.See details»
Types of Myelodysplastic Syndromes - American Cancer Society
The World Health Organization (WHO) classification system for MDS includes many of the gene and chromosome changes found inside MDS cells, as well as how the cells look under a …See details»
The 2016 Revision to the World Health Organization Classification …
Myelodysplastic syndromes (MDS) are a group of diverse clonal hematopoietic disorders characterized by ineffective hematopoiesis, manifested by morphologic dysplasia in …See details»
The Myelodysplastic Syndromes: Diagnosis and …
We review when to suspect MDS, detail how to evaluate patients who may have a form of the condition, explain key features of treatments that are currently available in the United States, and summarize a general, common-sense …See details»
Comparison of the 2022 world health organization classification …
Apr 9, 2024 · In 2022, two novel classification systems for myelodysplastic syndromes/neoplasms (MDS) have been proposed: the International Consensus Classification (ICC) and the 2022 …See details»
Clinical manifestations, diagnosis, and classification of ...
Jun 10, 2024 · Myelodysplastic syndromes/neoplasms (MDS) are a heterogeneous group of hematologic neoplasms characterized by clonal hematopoiesis, cytopenias (ie, anemia, …See details»
De Novo and Therapy-Related Myelodysplastic Syndromes: …
May 1, 2022 · The myelodysplastic syndromes (MDS) are a group of clonal bone marrow (BM) neoplasms characterized by ineffective hematopoiesis, manifested by morphologic dysplasia …See details»
The 5th edition of the World Health Organization Classification of ...
Jun 22, 2022 · The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers …See details»
Management of patients with lower-risk myelodysplastic …
Dec 14, 2022 · Patients with MDS can generally be classified as lower- (LR-MDS) or higher-risk (HR-MDS). As treatment goals for patients with LR-MDS and those with HR-MDS differ …See details»
Revised International Prognostic Scoring System (IPSS-R) for ...
Peter Greenberg, MD, is professor emeritus of hematology at Stanford University. He is also director of the Stanford Myelodysplastic Syndrome (MDS) Center, coordinator of the …See details»
Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment
The myelodysplastic syndromes (MDS) are a group of common malignant stem cell diseases, mainly encountered in older people; their clinical course varies greatly and they carry an …See details»
What Are Myelodysplastic Syndromes (MDS)? - American Cancer …
Myelodysplastic syndromes (MDS), also known as myelodysplastic neoplasms, are conditions that can occur when the blood-forming cells in the bone marrow become abnormal, resulting in …See details»
The new WHO 2022 and ICC proposals for the classification of ...
Jan 23, 2024 · Patients with ring sideroblasts (RS) were found in all WHO-defined subtypes but, by definition, mainly in the SF3B1 -mutated group. The highest percentage of complex …See details»
MDS-R | Moral Distress Scale-Revised described in ePROVIDE
Access up-to-date information on the Moral Distress Scale-Revised (MDS-R): copyright, licensing, scoring, translations, ...See details»
Moral distress and its contribution to the development of burnout ...
For data collection, a self-administered questionnaire for each critical care provider was used including basic demographic data, the Maslach Burnout Inventory (MBI) and the Moral …See details»
Comparison of the revised 4th (2016) and 5th (2022) editions of …
Oct 12, 2022 · A summary of the World Health Organization (WHO) 5th edition (2022) classification of myelodysplastic neoplasms (MDS) was recently published in LEUKEMIA [1]. …See details»
Poor prognostic implications of myelodysplasia-related mutations …
Jan 4, 2023 · In this study, we aimed to explore the association of MDS-R mutations with clinic-biological features, molecular genetic alterations, and prognostic relevance in both older and …See details»